Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
Phase 3
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2005-09-20
- Lead Sponsor
- New York Prostate Institute
- Target Recruit Count
- 150
- Registration Number
- NCT00201630
- Locations
- 🇺🇸
New York Prostate Institute, Oceanside, New York, United States
© Copyright 2025. All Rights Reserved by MedPath